Scripps Health cardiologist leads study of blood test’s ability to detect warning signs

Scientists have long suspected that CECs can become troublemakers when they become sickly. But their true impact ﻿only became obvious as advances in technology made it possible for researchers to more clearly see and analyze the cells. The newest version of the blood test genetically confirms the presence of sick CECs.



The earlier study also involved scientists and doctors from Veridex LLC, Palomar Health and Sharp HealthCare. The study was underwritten by a $2 million grant from the National Institutes of Health.


